Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Region Skane
Sponsor

Region Skane

Sweden Dockplatsen 26, Malmo S:t Petri, 211 74 Malmo, Sweden

About the sponsor

Research activity includes treatment strategies for non-small cell lung cancer, triple-negative breast cancer, dedifferentiated liposarcoma, mantle cell lymphoma, diffuse large B-cell lymphoma, gastrointestinal stromal tumor, and neuroendocrine tumours. Additional interest is seen in papillary craniopharyngioma and resectable gastric and gastroesophageal junction adenocarcinoma.

  • Solid tumours
  • Lymphoma
  • Targeted cancer therapy
  • Perioperative oncology

Its oncology portfolio spans both tumour-directed therapy and disease-specific management across adult and selected rare cancers.

About Specializations

Region Skane runs clinical trials in conditions such as Bipolar disorder, Endocrine ophthalmopathy, Major depression, Mantle cell lymphoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

34 clinical trials

Bipolar disorder

Recruiting

Effect of Adjunctive Pramipexole on Anhedonia in Adults with Bipolar Depression – Randomized, Double‑Blind, Placebo‑Controlled Phase III Trial

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Pramipexole
  • Sponsor:Region Skane

Hypertrophic cardiomyopathy

Recruiting

Study of Short‑and Long‑Term Hemodynamic and Physiological Effects of Mavacamten in Patients with Obstructive Hypertrophic Cardiomyopathy

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Mavacamten
  • Sponsor:Region Skane

Head and neck cancer

Recruiting

Indocyanine Green Fluorescence Imaging for Flap Perfusion in Head and Neck Cancer Reconstruction Surgery

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Indocyanine Green
  • Sponsor:Region Skane

Anorexia nervosa

Recruiting

Study on the Effects of Psilocybin for Young Adults with Anorexia Nervosa

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
  • Sponsor:Region Skane

Dementia+7

Recruiting

Study on the Accuracy of Tau PET ([18F]RO6958948) and Vizamyl (Flutemetamol 18F) in Diagnosing Mild Cognitive Symptoms and Risk of Alzheimer's Disease

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Flutemetamol (18F)
  • Sponsor:Region Skane

Myocardial ischaemia

Recruiting

Study on the Effects of Different Doses of Adenosine for Patients with Chronic Coronary Syndrome, with and without Heart Failure

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Adenosine
  • Sponsor:Region Skane

Non-small cell lung cancer

Recruiting

Study on EGFR-Mutated Lung Cancer: Evaluating Dacomitinib, Afatinib, and Osimertinib for Patients Not Suitable for Curative Treatment

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Afatinib
  • Sponsor:Region Skane

Endocrine ophthalmopathy

Recruiting

Study on Treating Graves' Eye Disease with Diclofenac or Simvastatin for Patients with Mild to Moderate Symptoms

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Simvastatin
  • Sponsor:Region Skane

Colitis ulcerative+1

Recruiting

Study on Stopping Infliximab and Adalimumab Treatment in Patients with Crohn's Disease and Ulcerative Colitis in Remission

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:Region Skane

Brain injury

Recruiting

Study of Brain Injury and Concussion Symptoms Using Tau Tracer [18F]RO6958948 in Patients with Traumatic Brain Injury and Hemorrhages

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:2-(6-[18F]Fluoro-Pyridin-3-Yl)-9H-Dipyrido[2,3-B:3',4'-D]Pyrrole
  • Sponsor:Region Skane

Staphylococcal bacteraemia

Recruiting

Study Comparing Benzylpenicillin and Cloxacillin for Treating Staphylococcus Aureus Blood Infection in Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Cloxacillin
  • Sponsor:Region Skane

Liposarcoma+2

Recruiting

Study of Pemigatinib and Retifanlimab for Patients with Advanced Dedifferentiated Liposarcoma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Pemigatinib
  • Sponsor:Region Skane

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.